the present invention relates to the combined medicinal treatment for cerebral venous u0434u0438u0441u0446u0438u0440u043au0443u043bu044fu0446u0438u0439, which u0442u0435u0440u0430u043fu0435u0432u0442u0438u0447u0435u0441u043au0438 effect u0438u0432u043du043eu0435 of venous u0430u043du0433u0438u043eu043fu0440u043eu0442u0435u043au0442u043eu0440u0430 u0442u0440u043eu043au0441u0435u0440u0443u0442u0438u043du0430 and u0442u0435u0440u0430u043fu0435u0432u0442u0438u0447u0435u0441u043au0438 effective amount of cerebral u0430u043du0433u0438u043eu043fu0440u043eu0442u0435u043au0442u043eu0440u0430 vinpocetine?, as well as to mode l u0435u0447u0435u043du0438u044f venous cerebral u0434u0438u0441u0446u0438u0440u043au0443u043bu044fu0446u0438u0439,the introduction of the drug or vehicle. the present invention also relates to a method of treatment of venous cerebral u0434u0438u0441u0446u0438u0440u043au0443u043bu044fu0446u0438u0439, which combined the effective number of tro u043au0441u0435u0440u0443u0442u0438u043du0430 and an effective amount of vinpocetine?.combined application of u0442u0440u043eu043au0441u0435u0440u0443u0442u0438u043du0430 and vinpocetine? significantly reduced evidence of objective and subjective neurological u0441u0438u043cu043fu0442u043eu043cu0430u0442u0438u043au0438 in venous. u0435u0440u0435u0431u0440u0430u043bu044cu043du044bu0445 u0434u0438u0441u0446u0438u0440u043au0443u043bu044fu0446u0438u044fu0445.
展开▼